THALIDOMIDE BMS 50 MG HARD CAPSULES Israel - English - Ministry of Health

thalidomide bms 50 mg hard capsules

neopharm ltd - thalidomide - hard capsule - thalidomide 50 mg - thalidomide - multiple myeloma : * for the treatment of multiple myeloma after failure of standard therapies. * thalidomide bms 50 mg hard capsules in combination with dexamethasone is indicated for the treatment of patients with newly diagnosed multiple myeloma. * thalidomide bms in combination with melphalan and prednisone is indicated for the treatment of patients with untreated multiple myeloma > or = 65 years or ineligible for high dose chemotherapy. erythema nodosum leprosum: for the acute treatment of the cutaneous manifestations of moderate to severe erythema nodosum leprosum (enl). thalidomide is not indicated as monotherapy for such enl treatment in the presence of moderate to severe neuritis. it is also indicated as maintenance therapy for prevention and suppression of the cutaneous manifestations of enl recurrence.

THALIDOMIDE CELGENE 50 MG HARD CAPSULES Israel - English - Ministry of Health

thalidomide celgene 50 mg hard capsules

neopharm ltd - thalidomide - hard capsule - thalidomide 50 mg - thalidomide - multiple myeloma : 1. for the treatment of multiple myeloma after failure of standars therapies. 2. thalidomide celgene 50 mg hard capsules in combination with dexamethasone is indicated for the treatment of patients with newly diagnosed multiple myeloma. 3. thalidomide celgene in combination with melphalan and prednisone is indicated for the treatment of patients with untreated multiple myeloma > or = 65 years or ineligible for high dose chemotherapy. erythema nodosum leprosum: 4. for the acute treatment of the cutaneous manifestations of moderate to severe erythema nodosum leprosum (enl). thalidomide is not indicated as monotherapy for such enl treatment in the presence of moderate to severe neuritis. it is also indicated as maintenance therapy for prevention and suppression of the cutaneous manifestations of enl recurrence.בקשה לעדכון משטר מינון 4/2/2020

Thalidomide Lipomed European Union - English - EMA (European Medicines Agency)

thalidomide lipomed

lipomed gmbh - thalidomide - multiple myeloma - immunosuppressants - thalidomide lipomed in combination with melphalan and prednisone is indicated as first line treatment of patients with untreated multiple myeloma, aged ≥ 65 years or ineligible for high dose chemotherapy.thalidomide lipomed is prescribed and dispensed in accordance with the thalidomide lipomed pregnancy prevention programme (see section 4.4).

Thalidomide BMS (previously Thalidomide Celgene) European Union - English - EMA (European Medicines Agency)

thalidomide bms (previously thalidomide celgene)

bristol-myers squibb pharma eeig - thalidomide - multiple myeloma - immunosuppressants - thalidomide bms in combination with melphalan and prednisone as first line treatment of patients with untreated multiple myeloma, aged >/= 65 years or ineligible for high dose chemotherapy.thalidomide bms is prescribed and dispensed according to the thalidomide celgene pregnancy prevention programme (see section 4.4).

Thalidomide Accord 50mg Hard Capsules Malta - English - Medicines Authority

thalidomide accord 50mg hard capsules

accord healthcare ireland ltd euro house, euro business park, little island cork, t45 k857, ireland - thalidomide - hard capsule - thalidomide 50 mg - immunosuppressants